Pharmacokinetics of CAMPATH-1H: assay development and validation (Q40756989)

23 September 2017

title

Pharmacokinetics of CAMPATH-1H: assay development and validation (English)

1 reference

23 September 2017

1 reference

2

Geoff Hale

1 reference

23 September 2017

Peppy Rebello

1

1 reference

23 September 2017

publication date

1 February 2002

1 reference

Journal of Immunological Methods

23 September 2017

published in

1 reference

23 September 2017

volume

260

1 reference

23 September 2017

issue

1-2

1 reference

23 September 2017

page(s)

285-302

1 reference

Association of serum Rituximab (IDEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin's lymphoma

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900556-7

Importance of antigen specificity for complement-mediated lysis by monoclonal antibodies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900556-7

A rapid solid-phase enzyme-linked binding assay for screening monoclonal antibodies to cell surface antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900556-7

A simple method for measuring patient anti-globulin responses against isotypic or idiotypic determinants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900556-7

Human cutaneous T cell lymphoma and leukemia cell lines produce and respond to T cell growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900556-7

Synthetic peptide mimotope of the CAMPATH-1 (CD52) antigen, a small glycosylphosphatidylinositol-anchored glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900556-7

Reactivity of rat monoclonal antibody CAMPATH-1 with human leukaemia cells and its possible application for autologous bone marrow transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900556-7

Rituximab (IDEC-C2B8): validation of a sensitive enzyme-linked immunoassay applied to a clinical pharmacokinetic study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900556-7

CAMPATH-1H in rheumatoid arthritis--an intravenous dose-ranging study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900556-7

Disposition and immunodynamics of basiliximab in liver allograft recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900556-7

A population pharmacokinetic-pharmacodynamic analysis of single doses of clenoliximab in patients with rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900556-7

Complex translocation t(8;12;14) in a cell line derived from a child with nonendemic Burkitt-type acute lymphoblastic leukemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900556-7

An improved assay for antibody dependent cellular cytotoxicity based on time resolved fluorometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900556-7

Manufacture and quality control of CAMPATH-1 antibodies for clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900556-7

Anti-globulin responses to rat and humanized CAMPATH-1 monoclonal antibody used to treat transplant rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900556-7

Pharmacokinetics of CAMPATH-1H in BMT patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900556-7

Reshaping human antibodies for therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900556-7

Dose escalation and pharmacokinetic study of a humanized anti-HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900556-7

Characterization of the CAMPATH-1 (CDw52) antigen: biochemical analysis and cDNA cloning reveal an unusually small peptide backbone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900556-7

10.1016/S0022-1759(01)00556-7

7 January 2021

Identifiers

DOI

1 reference

23 September 2017

1 reference